NCT00955149: Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC) |
|
|
| Completed | 1 | 6 | US | Erlotinib (Tarceva) | Mayo Clinic, Genentech, Inc. | Primary Sclerosing Cholangitis, Trisomy 7, Cholangiocarcinoma, Chemoprevention | 04/13 | 04/13 | | |
